A Holistic Approach in Treating Heart Failure with Prosystole

  • R Balaji Research and Development, Regenix Drugs Limited, Chennai, Tamil Nadu, India.
  • A Ramamurthy Research and Development, Regenix Drugs Limited, Chennai, Tamil Nadu, India.
  • Senthil Devi Research and Development, Regenix Drugs Limited, Chennai, Tamil Nadu, India.
  • M Chokkalingam Department of Cardiology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.
  • K Lakshmi Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India
Keywords: Cardiovascular Diseases, Nutritional Supplement, Medication, Prosystole


Due to the rising interest in personal health, ageing population and promising solutions for individualised treatment, the market for nutritional supplements is anticipated to rise by more than 6% per year through 2018. Fish oil, vitamin D, multivitamins and coenzyme Q10 (CoQ10) are the most popular dietary supplements. Probiotics are also the supplement with the fastest rate of growth in this ranking. One of the largest global burdens of cardiovascular disease (CVD) is seen in India. According to projections, there would be 4.77 million CVD deaths in India annually by 2025, up from 2.26 million in 1990. Although the causes of increased CVD risk factor incidence rates are complicated, they probably involve urbanisation-related lifestyle changes as well as epidemiological and dietary changes brought on by economic development. This review brings in the significance of nutritional supplements as adjuvant therapy in the treatment of cardiovascular diseases.

How to cite this article:
Balaji R, Ramamurthy A, Devi S, Chokkalingam M, Lakshmi K. A Holistic Approach in Treating Heart Failure with Prosystole. Chettinad Health City Med J. 2023;12(1):65-69.

DOI: https://doi.org/10.24321/2278.2044.202311


Huffman MD, Prabhakaran D, Osmond C, Fall CH, Tandon N, Lakshmy R, Ramji S, Khalil A, Gera T, Prabhakaran P, Biswas SK, Reddy KS, Bhargava SK, Sachdev HS; New Delhi Birth Cohort. Incidence of cardiovascular risk factors in an Indian urban cohort results from the New Delhi birth cohort. J Am Coll Cardiol. 2011 Apr 26;57(17):1765-74. [PubMed] [Google Scholar]

Bronzato S, Durante A. Dietary supplements and cardiovascular diseases. Int J Prev Med. 2018;9:80. [PubMed] [Google Scholar]

Witting PK, Pettersson K, Letters J, Stocker R. Antiatherogenic effect of coenzyme Q10 in apolipoprotein E gene knockout mice. Free Radic Biol Med. 2000;29:295-305. [PubMed] [Google Scholar]

Tsai KL, Huang YH, Kao CL, Yang DM, Lee HC, Chou HY, Chen YC, Chiou GY, Chen LH, Yang YP, Chiu TH, Tsai CS, Ou HC, Chiou SH. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NOrelated pathways. J Nutr Biochem. 2012;23:458-68. [PubMed] [Google Scholar]

Sharma A, Fonarow GC, Butler J, Ezekowitz JA, Felker GM. Coenzyme Q10 and heart failure: a state-of-the-art review. Circ Heart Fail. 2016;9(4):e002639. [PubMed] [Google Scholar]

Lee BJ, Huang YC, Chen SJ, Lin PT. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition. 2012;28(3):250-5. [PubMed] [Google Scholar]

González-Guardia L, Yubero-Serrano EM, Delgado-Lista J, Perez-Martinez P, Garcia-Rios A, Marin C, Camargo A, Delgado-Casado N, Roche HM, Perez-Jimenez F, Brennan L, Lopez-Miranda J. Effects of the Mediterranean diet supplemented with coenzyme q10 on metabolomic profiles in elderly men and women. J Gerontol A Biol Sci Med Sci. 2015;70(1):78-84. [PubMed] [Google Scholar]

Yubero-Serrano EM, Gonzalez-Guardia L, Rangel-Zuñiga O, Delgado-Lista J, Gutierrez-Mariscal FM, Perez-Martinez P, Delgado-Casado N, Cruz-Teno C, Tinahones FJ, Villalba JM, Perez-Jimenez F, Lopez-Miranda J. Mediterranean diet supplemented with coenzyme Q10 modifies the expression of proinflammatory and endoplasmic reticulum stress-related genes in elderly men and women. J Gerontol A Biol Sci Med Sci. 2012;67(1):3-10. [PubMed] [Google Scholar]

DiNicolantonio JJ, Liu J, O’Keefe JH. Magnesium for the prevention and treatment of cardiovascular disease. Open Heart. 2018;5(2):e000775. [PubMed] [Google Scholar]

Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY. L-carnitine and heart disease. Life Sci. 2018;194(1):88-97. [PubMed] [Google Scholar]

DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O’Keefe JH. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and metaanalysis. Mayo Clin Proc. 2013;88(6):544-51. [PubMed] [Google Scholar]

Omori Y, Ohtani T, Sakata Y, Mano T, Takeda Y, Tamaki S, Tsukamoto Y, Kamimura D, Aizawa Y, Miwa T, Komuro I, Soga T, Yamamoto K. L-carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease. J Hypertens. 2012;30(9):1834-44. [PubMed] [Google Scholar]

Orlandi A, Francesconi A, Ferlosio A, Lascio AD, Marcellini M, Pisano C, Spagnoli LG. Propionyl-Lcarnitine prevents age-related myocardial remodeling in the rabbit. J Cardiovasc Pharmacol. 2007;50(2):168-75. [PubMed] [Google Scholar]

Dzugkoev SG, Mozhaeva IV, Otiev MA, Margieva OI, Dzugkoeva FS. [Effect of L-carnitine, afobazole and their combination with L-arginine on biochemical and histological indices of endothelial dysfunctions in cobalt intoxication in rats]. Patol Fiziol Eksp Ter. 2015;59(2):70-5. Russian. [PubMed] [Google Scholar]

Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C. Therapeutic effects of L-carnitine and propionyl-Lcarnitine on cardiovascular diseases: a review. Ann NY Acad Sci. 2004 Nov;1033:79-91. [PubMed] [Google Scholar]

Kris-Etherton PM, Harris WS, Appel LJ; AHA Nutrition Committee; American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):151-2. [PubMed] [Google Scholar]

Stone NJ. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation. 1996;94(9):2337-40. [PubMed] [Google Scholar]

Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids and cardiovascular disease. Circulation. 2002;106(21):2747-57. [PubMed] [Google Scholar]

Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman Jr JW, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, Jeor SS, Suttie J, Tribble DL, Bazzarre TL. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 2000;102(18):2284-99. [PubMed] [Google Scholar]

Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1993;72(15):1156-62. [PubMed] [Google Scholar]

Raj V, Ojha S, Howarth FC, Belur PD, Subramanya SB. Therapeutic potential of benfotiamine and its molecular targets. Eur Rev Med Pharmacol Sci. 2018;22(10):3261-73. [PubMed] [Google Scholar]

Garson KL, Mapanga RF, Milne R, Essop MF. The effects of benfotiamine in attenuating hyperglycemia-induced cardiac pathology. J Afr Assoc Physiol Sci. 2010;2(1):5-13. [Google Scholar]

Mozos I, Stoian D, Caraba A, Malainer C, Horbańczuk JO, Atanasov AG. Lycopene and vascular health. Front Pharmacol. 2018;9:521. [PubMed] [Google Scholar]

Verhaar MC, Stroes E, Rabelink TJ. Folates and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2002;22(1):6-13. [PubMed] [Google Scholar]

Earnest CP, Wood KA, Church TS. Complex multivitamin supplementation improves homocysteine and resistance to LDL-C oxidation. J Am Coll Nutr. 2003;22(5):400-7. [PubMed] [Google Scholar]